E2F1 and Miyoshi myopathy: Among MICA/B-positive regulators, only E2F1 was significantly upregulated, while, among negative regulators, IRF4 and IKZF1 were downregulated in MM cell lines treated with trabectedin as compared to control (Fig. 5c).